Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine Uses, Dosage, Side Effects and more

Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup W-135. The vaccine contains* N. meningitis* serogroup y capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are extracted from Corynebacterium diphtheriae grown in another culture.

Trade Name Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine
Generic Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen
Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen Other Names Neisseria meningitidis serogroup Y capsular polysaccharide diphtheria toxoid protein conjugate vaccine
Type
Groups Approved
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share